Modality of renal replacement therapy and survival in the population of children with end-stage renal disease

Background. Survival in the population of children with end-stage renal disease is multifactorial and depends on the diffe­rent characteristics of the patient and treatment, as well as on the degree of economic well-being of the country in which the treatment is taking place. While other patient-rel...

Full description

Bibliographic Details
Main Author: S.V. Kushnirenko
Format: Article
Language:English
Published: Zaslavsky O.Yu. 2019-03-01
Series:Počki
Subjects:
Online Access:http://kidneys.zaslavsky.com.ua/article/view/166667
_version_ 1819281782669836288
author S.V. Kushnirenko
author_facet S.V. Kushnirenko
author_sort S.V. Kushnirenko
collection DOAJ
description Background. Survival in the population of children with end-stage renal disease is multifactorial and depends on the diffe­rent characteristics of the patient and treatment, as well as on the degree of economic well-being of the country in which the treatment is taking place. While other patient-related aspects, such as growth, psychosocial development and quality of life, are important, extending patient survival is perhaps the most important clinical task. The aim of the study was to analyze the modality of renal replacement therapy and survival in the population of children with end-stage renal disease, based on a database of children in Kyiv who received renal replacement therapy from 2006 to 2018, using the example of the Kyiv Municipal Children’s Nephrology Centre. Materials and methods. In 40 children with chronic kidney disease stage 5 who received renal replacement therapy, modality of renal replacement therapy methods, primary renal diseases, gender and age characteristics, anthropometric data, glomerular filtration rate at the beginning of renal replacement therapy, residual kidney function, comorbidity and their effect on patients’ survival were analyzed. Results. Among 40 patients who started renal replacement therapy from 2006 to 2018 in Kyiv Municipal Children’s Nephro­logy Centre, the modality at baseline is represented by hemodialysis in 80 %, by preemptive kidney transplantation — in 12.5 %, by peritoneal dialysis — in 7.5 % of cases. The duration of renal replacement therapy ranged from 28 to 199 months. The majority of patients began treatment with hemodialysis at the age of 10–14 years (42.9 %). Kidney transplantation in children mainly occurred in 15–17 years (33.3 %). In total, the number of female patients on renal replacement therapy (hemodialysis and peritoneal dialysis) was 57.1 %, and that of men — 42.9 %. Among the patients with a transplanted kidney, 66.7 % are females and 33.3 % are males. In the majority of patients (> 50 %), primary renal diseases are represented by congenital anomalies of the kidney and the urinary tract; 10 % of children on renal replacement therapy had multiple congenital malformations (of the brain, heart, lungs), the syndromic diagnosis was recorded in 7.5 % of patients. Delayed psychomotor development was noted in 12.5 % of patients. Analysis of the obtained results showed that 48.6 % of children on hemodialysis and peritoneal dialysis were stunted, 51.4 % had arterial hypertension. With a glomerular filtration rate in the range of 8–15 ml/min/1.73 m2, 55 % of patients started treatment with renal replacement therapy. Conclusions. Survival of patients with end-stage renal disease is multifactorial, largely depends on access to treatment, health care costs in the country, etiology of the disease, age, sex, anthropometric parameters, the possibility of transplantation and the presence of concomitant diseases. Five-year survival rate of patients on renal replacement therapy for 2006–2018 in Kyiv Municipal Children’s Nephrology Centre was 93.1 %, 10-year survival rate — 83.3 %.
first_indexed 2024-12-24T01:05:10Z
format Article
id doaj.art-c9ba14b5b3e8441d9a3a9cf1c5dad910
institution Directory Open Access Journal
issn 2307-1257
2307-1265
language English
last_indexed 2024-12-24T01:05:10Z
publishDate 2019-03-01
publisher Zaslavsky O.Yu.
record_format Article
series Počki
spelling doaj.art-c9ba14b5b3e8441d9a3a9cf1c5dad9102022-12-21T17:23:14ZengZaslavsky O.Yu.Počki2307-12572307-12652019-03-018211412310.22141/2307-1257.8.2.2019.166667166667Modality of renal replacement therapy and survival in the population of children with end-stage renal diseaseS.V. Kushnirenko0Shupyk National Medical Academy of Postgraduate Education, Kyiv, UkraineBackground. Survival in the population of children with end-stage renal disease is multifactorial and depends on the diffe­rent characteristics of the patient and treatment, as well as on the degree of economic well-being of the country in which the treatment is taking place. While other patient-related aspects, such as growth, psychosocial development and quality of life, are important, extending patient survival is perhaps the most important clinical task. The aim of the study was to analyze the modality of renal replacement therapy and survival in the population of children with end-stage renal disease, based on a database of children in Kyiv who received renal replacement therapy from 2006 to 2018, using the example of the Kyiv Municipal Children’s Nephrology Centre. Materials and methods. In 40 children with chronic kidney disease stage 5 who received renal replacement therapy, modality of renal replacement therapy methods, primary renal diseases, gender and age characteristics, anthropometric data, glomerular filtration rate at the beginning of renal replacement therapy, residual kidney function, comorbidity and their effect on patients’ survival were analyzed. Results. Among 40 patients who started renal replacement therapy from 2006 to 2018 in Kyiv Municipal Children’s Nephro­logy Centre, the modality at baseline is represented by hemodialysis in 80 %, by preemptive kidney transplantation — in 12.5 %, by peritoneal dialysis — in 7.5 % of cases. The duration of renal replacement therapy ranged from 28 to 199 months. The majority of patients began treatment with hemodialysis at the age of 10–14 years (42.9 %). Kidney transplantation in children mainly occurred in 15–17 years (33.3 %). In total, the number of female patients on renal replacement therapy (hemodialysis and peritoneal dialysis) was 57.1 %, and that of men — 42.9 %. Among the patients with a transplanted kidney, 66.7 % are females and 33.3 % are males. In the majority of patients (> 50 %), primary renal diseases are represented by congenital anomalies of the kidney and the urinary tract; 10 % of children on renal replacement therapy had multiple congenital malformations (of the brain, heart, lungs), the syndromic diagnosis was recorded in 7.5 % of patients. Delayed psychomotor development was noted in 12.5 % of patients. Analysis of the obtained results showed that 48.6 % of children on hemodialysis and peritoneal dialysis were stunted, 51.4 % had arterial hypertension. With a glomerular filtration rate in the range of 8–15 ml/min/1.73 m2, 55 % of patients started treatment with renal replacement therapy. Conclusions. Survival of patients with end-stage renal disease is multifactorial, largely depends on access to treatment, health care costs in the country, etiology of the disease, age, sex, anthropometric parameters, the possibility of transplantation and the presence of concomitant diseases. Five-year survival rate of patients on renal replacement therapy for 2006–2018 in Kyiv Municipal Children’s Nephrology Centre was 93.1 %, 10-year survival rate — 83.3 %.http://kidneys.zaslavsky.com.ua/article/view/166667renal replacement therapychildrensurvival
spellingShingle S.V. Kushnirenko
Modality of renal replacement therapy and survival in the population of children with end-stage renal disease
Počki
renal replacement therapy
children
survival
title Modality of renal replacement therapy and survival in the population of children with end-stage renal disease
title_full Modality of renal replacement therapy and survival in the population of children with end-stage renal disease
title_fullStr Modality of renal replacement therapy and survival in the population of children with end-stage renal disease
title_full_unstemmed Modality of renal replacement therapy and survival in the population of children with end-stage renal disease
title_short Modality of renal replacement therapy and survival in the population of children with end-stage renal disease
title_sort modality of renal replacement therapy and survival in the population of children with end stage renal disease
topic renal replacement therapy
children
survival
url http://kidneys.zaslavsky.com.ua/article/view/166667
work_keys_str_mv AT svkushnirenko modalityofrenalreplacementtherapyandsurvivalinthepopulationofchildrenwithendstagerenaldisease